Lipid autacoids in inflammation and injury responses: A matter of privilege

Molecular Interventions

Volumn 8, Issue 1, 2008, Pages 28-35

  Gronert, Karsten ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AUTACOID; HEME OXYGENASE; LIPID; LIPOXYGENASE; PROSTAGLANDIN SYNTHASE;

BIOLOGY; CELL PROTECTION; CORNEA; HOST RESISTANCE; HUMAN; INFECTION; INFLAMMATION; LEUKOCYTE ACTIVATION; MEDICAL SPECIALIST; MUCOSA; NEUTROPHIL; NONHUMAN; PERMEABILITY BARRIER; REGULATORY MECHANISM; REVIEW; SKIN; TISSUE; TISSUE INJURY; WOUND HEALING; WOUND HEALING IMPAIRMENT;

ANIMALS; AUTACOIDS; CORNEA; HEME OXYGENASE (DECYCLIZING); HUMANS; INFLAMMATION; LEUKOCYTES; LIPIDS; LIPOXYGENASE; MICE; NEUTROPHILS; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 40849085188     PISSN: 15340384     EISSN: 15432548     Source Type: Journal    
DOI: 10.1124/mi.8.1.7     Document Type: Review

References (74)

1. Kumar, V., Fausto, N., and Abbas, A. Robbins and Cotran Pathologic Basis of Disease. W.B. Saunders Company, Philadelphia (2004).
2. Streilein, J. W. Ocular immune privilege: Therapeutic opportunities from an experiment of nature. Nat. Rev.. Immuno. 3, 879-889 (2003).
3. Lawrence, T., Willoughby, D.A., and Gilroy, D.W. Anti-inflammatory lipid mediators and insights into the resolution of inflammation. Nat. Rev. Immunol. 2, 787-795 (2002).
4. Serhan, C.N., Brain, S.D., Buckley, C.D., Gilroy, D.W., Haslett, C., O'Neill, L.A., Perretti, M., Rossi, A.G., and Wallace, J.L. Resolution of inflammation: state of the art, definitions and terms. FASEB J. 21, 325-332 (2007).
5. Martin, P. and Leibovich, S.J. Inflammatory cells during wound repair: The good, the bad and the ugly. Trends Cell Biol. 15, 599-607 (2005).
6. Oberyszyn, T.M. Inflammation and wound healing. Front. Biosci. 12, 2993-2999 (2007).
7. Raja, Sivamani, K., Garcia, M.S., and Isseroff, R.R. Wound re-epithelialization: modulating keratinocyte migration in wound healing. Front. Biosci 12, 2849-2868 (2007).
8. Gillitzer, R. and Goebeler, M. Chemokines in cutaneous wound healing. J. Leukoc. Biol. 69, 513-521 (2001).
9. Dovi, JV., Szpaderska, A.M., and DiPietro, L.A. Neutrophil function in the healing wound: Adding insult to injury? Thromb. Haemost. 92, 275-280 (2004).
10. Simpson, D.M. and Ross, R. The neutrophilic leukocyte in wound repair a study with antineutrophil serum. J. Clin. Invest. 51, 2009-2023 (1972).
11. Streilein, J.W. Ocular immune privilege: The eye takes a dim but practical view of immunity and inflammation. J. Leukoc. Biol. 74, 179-185 (2003).
12. Szpaderska, A.M., Zuckerman, J.D., and DiPietro, L.A. Differential injury responses in oral mucosal and cutaneous wounds. J. Dent. Res. 82, 621-626 (2003).
13. Niederkorn, J.Y. The immune privilege of corneal grafts. J. Leukoc. Biol. 74, 167-171 (2003).
14. Gronert, K. Lipoxins in the eye and their role in wound healing. Prostaglandins Leukot. Essent. Fatty Acids 73, 221-229 (2005).
15. McMahon, B., Mitchell, S., Brady, H. R., and Godson, C. Lipoxins: Revelations on resolution. Trends Pharmacol. Sci. 22, 391-395 (2001).
16. Serhan, C.N. and Savill, J. Resolution of inflammation: The beginning programs the end. Nat. Immunol. 6, 1191-1197 (2005).
17. Rajakariar, R., Yaqoob, M.M., and Gilroy, D.W. COX-2 in inflammation and resolution. Mol. Interv. 6, 199-207 (2006).
18. Wilson, G., O'Leary, D.J., and Holden, B.A. Cell content of tears following overnight wear of a contact lens. Curr. Eye Res. 8, 329-335 (1989).
19. Sack, R.A., Tan, K.O., and Tan, A. Diurnal tear cycle: Evidence for a nocturnal inflammatory constitutive tear fluid. Invest. Ophthalmol. Vis. Sci. 33, 626-640 (1992).
20. Li, Z., Burns, A.R., and Smith, C.W. Two waves of neutrophil emigration in response to corneal epithelial abrasion: distinct adhesion molecule requirements. Invest. Ophthalmol. Vis. Sci. 47, 1947-1955 (2006).
21. Vij, N., Roberts, L., Joyce, S., and Chakravarti, S. Lumican regulates corneal inflammatory responses by modulating Fas-Fas ligand signaling. Invest. Ophthalmol. Vis. Sci. 46, 88-95 (2005).
22. Li, Z., Rumbaut, R.E., Burns, A.R., and Smith, C. W. Platelet response to corneal abrasion is necessary for acute inflammation and efficient reepithelialization. Invest. Ophthalmol. Vis. Sci. 47, 4794-4802 (2006).
23. Gronert, K., Maheshwari, N., Khan, N., Hassan, I.R., Dunn, M., and Laniado Schwartzman, M. A role for the mouse 12/15-lipoxygenase pathway in promoting epithelial wound healing and host defense. J. Biol. Chem. 280, 15267-15278 (2005).
24. Ueno, M., Lyons, B.L., Burzenski, L.M., Gott, B., Shaffer, D.J., Roopenian, D.C., and Shultz, L.D. Accelerated wound healing of alkaliburned corneas in MRL mice is associated with a reduced inflammatory signature. Invest. Ophthalmol. Vis. Sci. 46, 4097-4106 (2005).
25. Biteman, B., Hassan, I.R., Walker, E., Leedom, A.J., Dunn, M., Seta, F., Laniado-Schwartzman, M., and Gronert, K. Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during epithelial wound healing. FASEB J. (in press).
26. Funk, C.D. Prostaglandins and leukotrienes: Advances in eicosanoid biology. Science 294, 1871-1875 (2001).
27. Chiang, N., Serhan, C.N., Dahlen, S.E., Drazen, J.M., Hay, D.W., Rovati, G.E., Shimizu, T., Yokomizo, T., and Brink, C. The lipoxin receptor ALX: Potent ligand-specific and stereoselective actions in vivo. Pharmacol. Rev. 58, 463-487 (2006).
28. Imig, J.D. Eicosanoids and renal vascular function in diseases. Clin. Sci. (Lond) 111, 21-34 (2006).
29. Serhan, C.N. Resolution phases of inflammation: Novel endogenous anti-inflammatory and proresolving lipid mediators and pathways. Annu. Rev. Immunol. 25, 101-137 (2006).
30. Bazan, N.G. Cell survival matters: Docosahexaenoic acid signaling, neuroprotection and photoreceptors. Trends Neurosci. 29, 263-271 (2006).
31. Lands, W.E. Biochemistry and physiology of n-3 fatty acids. FASEB J. 6, 2530-2536 (1992).
32. Arterburn, L.M., Hall, E.B., and Oken, H. Distribution, interconversion, and dose response of n-3 fatty acids in humans. Am. J. Clin. Nutr. 83, 1467S-1476S (2006).
33. Gilroy, D.W., Lawrence, T., Perretti, M., and Rossi, A.G. Inflammatory resolution: New opportunities for drug discovery. Nat. Rev. Drug Discov. 3, 401-416 (2004).
34. Parkinson, J.F. Lipoxin and synthetic lipoxin analogs: An overview of anti-inflammatory functions and new concepts in immunomodulation. Inflamm. Allergy Drug Targets 5, 91-106 (2006).
35. McMahon, B. and Godson, C. Lipoxins: Endogenous regulators of inflammation. Am. J. Physiol. Renal Physiol. 286, F189-201 (2004).
36. Schwab, J.M., Chiang, N., Arita, M., and Serhan, C.N. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 447, 869-874 (2007).
37. Godson, C., Mitchell, S., Harvey, K., Petasis, N.A., Hogg, N., and Brady, H.R.: Lipoxins rapidly stimulate nonphlogistic phagocytosis of apoptotic neutrophils by monocyte-derived macrophages. J. Immunol. 164, 1663-1667 (2000).
38. FitzGerald, G.A. COX-2 and beyond: Approaches to prostaglandin inhibition in human disease. Nat. Rev. Drug Discov. 2, 879-890 (2003).
39. Li, L., Pettit, A.R., Gregory, L.S., and Forwood, M.R. Regulation of bone biology by prostaglandin endoperoxide H synthases (PGHS): A rose by any other name. Cytokine Growth Factor Rev. 17, 203-216 (2006).
40. Van Dyke, T.E. and Serhan, C.N. Resolution of inflammation: A new paradigm for the pathogenesis of periodontal diseases. J. Dent. Res. 82, 82-90 (2003).
41. Reuter, B.K., Asfaha, S., Buret, A., Sharkey, K.A., and Wallace, J.L. Exacerbation of inflammation-associated colonic injury in rat through inhibition of cyclooxygenase-2. J. Clin. Invest. 98, 2076-2085 (1996).
42. Wallace, J.L., de Lima, O.M., Jr., and Fiorucci, S. Lipoxins in gastric mucosal health and disease. Prostaglandins Leukot. Essent. Fatty Acids 73, 251-255 (2005).
43. Levy, B.D., Clish, C.B., Schmidt, B., Gronert, K., and Serhan, C.N. Lipid mediator class switching during acute inflammation: Signals in resolution. Nat. Immunol. 2, 612-619 (2001).
44. Bonnans, C., Fukunaga, K., Levy, M.A., and Levy, B.D. Lipoxin A(4) regulates bronchial epithelial cell responses to acid injury. Am. J. Pathol. 168, 1064-1072 (2006).
45. Kapoor, M., Kojima, F., Yang, L., and Crofford, L.J. Sequential induction of pro- and anti-inflammatory prostaglandins and peroxisome proliferators-activated receptor-gamma during normal wound healing: a time course study. Prostaglandins Leukot. Essent. Fatty Acids 76, 103-112 (2007).
46. Sandulache, V.C., Parekh, A., Li-Korotky, H.S., Dohar, J.E., and Hebda, P.A. Prostaglandin E2 differentially modulates human fetal and adult dermal fibroblast migration and contraction: Implication for wound healing. Wound Repair Regen. 14, 633-643 (2006).
47. Bonner, J.C., Rice, A.B., Ingram, J.L.et al. Susceptibility of cyclooxygenase-2-deficient mice to pulmonary fibrogenesis. Am. J. Pathol. 161, 459-470 (2002).
48. Kolodsick, J.E., Peters-Golden, M., Larios, J., Toews, G.B., Thannickal, V.J., and Moore, B.B. Prostaglandin E2 inhibits fibroblast to myofibroblast transition via E. prostanoid receptor 2 signaling and cyclic adenosine monophosphate elevation. Am. J. Respir. Cell Mol. Biol. 29, 537-544 (2003).
49. Charbeneau, R.P. and Peters-Golden, M. Eicosanoids: Mediators and therapeutic targets in fibrotic lung disease. Clin. Sci. (Lond) 108, 479-491 (2005).
50. Kampfer, H., Schmidt, R., Geisslinger, G., Pfeilschifter, J., and Frank, S. Wound inflammation in diabetic ob/ob mice: Functional coupling of prostaglandin biosynthesis to cyclooxygenase-1 activity in diabetes-impaired wound healing. Diabetes 54, 1543-1551 (2005).
51. Funk, C.D., Chen, X.S., Johnson, E.N., and Zhao, L. Lipoxygenase genes and their targeted disruption. Prostaglandins Other Lipid Mediat. 68-69, 303-312 (2002).
52. Bradding, P., Redington, A.E., Djukanovic, R., Conrad, D.J., and Holgate, S.T. 15-lipoxygenase immunoreactivity in normal and in asthmatic airways. Am. J. Respir. Crit. Care Med. 151, 1201-1204 (1995).
53. Brash, A.R., Yu, Z., Boeglin, W.E., and Schneider, C. The hepoxilin connection in the epidermis. FEBS J. 274, 3494-3502 (2007).
54. Johnson, E.N., Nanney, L.B., Virmani, J., Lawson, J.A., and Funk, C.D. Basal transepidermal water loss is increased in platelet-type 12-lipoxygenase deficient mice. J. Invest. Dermatol. 112, 861-865 (1999).
55. Yu, Z., Schneider, C., Boeglin, W.E., and Brash, A.R. Mutations associated with a congenital form of ichthyosis (NCIE) inactivate the epidermal lipoxygenases 12R-LOX and eLOX3. Biochim. Biophys. Acta 1686 3, 238-247 (2005).
56. Ziboh, V.A., Miller, C.C., and Cho, Y. Significance of lipoxygenase-derived monohydroxy fatty acids in cutaneous biology. Prostaglandins Other Lipid Mediat. 63, 3-13 (2000).
57. Kuhn, H., and O'Donnell, V. B. Inflammation and immune regulation by 12/15-lipoxygenases. Prog. Lipid Res. 45, 334-356 (2006).
58. Liminga, M., Hornsten, L., Sprecher, H.W., and Oliw, E.H. Arachidonate 15-lipoxygenase in human corneal epithelium and 12- and 15-lipoxygenases in bovine corneal epithelium: comparison with other bovine 12-lipoxygenases. Biochim. Biophys. Acta 1210, 288-296 (1994).
59. Bonnans, C., Chanez, P., and Chavis, C. Lipoxins in asthma: potential therapeutic mediators on bronchial inflammation? Allergy 59, 1027-1041 (2004).
60. Vance, R.E., Hong, S., Gronert, K., Serhan, C.N., and Mekalanos, J.J. The opportunistic pathogen Pseudomonas aeruginosa carries a secretable arachidonate 15-lipoxygenase. Proc. Natl. Acad. Sci. USA 101, 2135-2139 (2004).
61. Aliberti, J., Serhan, C., and Sher, A. Parasite-induced lipoxin A4 is an endogenous regulator of IL-12 production and immunopathology in Toxoplasma gondii infection. J. Exp. Med. 196, 1253-1262 (2002).
62. Chang, M.S., Schneider, C., Roberts, R.L., Shappell, S.B., Haselton, F.R., Boeglin, W.E., and Brash, A.R. Detection and subcellular localization of two 15S-lipoxygenases in human cornea. Invest. Ophthalmol. Vis. Sci. 46, 849-856 (2005).
63. Gronert, K., Gewirtz, A., Madara, J.L., and Serhan, C.N. Identification of a human enterocyte lipoxin A4 receptor that is regulated by interleukin (IL)-13 and interferon gamma and inhibits tumor necrosis factor alpha-induced IL-8 release. J. Exp. Med. 187, 1285-1294 (1998).
64. Bazan, H.E. Cellular and molecular events in corneal wound healing: Significance of lipid signalling. Exp. Eye Res. 80, 453-463 (2005).
65. Seta, F., Bellner, L., Rezzani, R., Regan, R.F., Dunn, M.W., Abraham, N.G., Gronert, K., and Laniado-Schwartzman, M. Heme-oxygenase-2 is a critical determinant for execution of an acute inflammatory and reparative response. Am. J. Pathol. 169, 1612-1623 (2006).
66. Laniado-Schwartzman, M., Abraham, N.G., Conners, M., Dunn, M.W., Levere, R.D., and Kappas, A. Heme oxygenase induction with attenuation of experimentally induced corneal inflammation. Biochem. Pharmacol. 53, 1069-1075 (1997).
67. Otterbein, L.E., Soares, M.P., Yamashita, K., and Bach, F.H. Heme oxygenase-1: Unleashing the protective properties of heme. Trends Immunol. 24, 449-455 (2003).
68. Hanselmann, C., Mauch, C., and Werner, S. Haem oxygenase-1: A novel player in cutaneous wound repair and psoriasis? Biochem. J. 353, 459-466 (2001).
69. Hegazi, R.A., Rao, K.N., Mayle, A., Sepulveda, A.R., Otterbein, L.E., and Plevy, S.E. Carbon monoxide ameliorates chronic murine colitis through a heme oxygenase 1-dependent pathway. J. Exp. Med. 202, 1703-1713 (2005).
70. Ryter, S.W., Alam, J., and Choi, A.M. Heme oxygenase-1/carbon monoxide: From basic science to therapeutic applications. Physiol. Rev. 86, 583-650 (2006).
71. Nascimento-Silva, V., Arruda, M.A., Barja-Fidalgo, C., Villela, C. G., and Fierro, I.M. Novel lipid mediator aspirin-triggered lipoxin A4 induces heme oxygenase-1 in endothelial cells. Am. J. Physiol. Cell Physiol. 289, C557-563 (2005).
72. Koizumi, T., Odani, N., Okuyama, T., Ichikawa, A., and Negishi, M. Identification of a cis-regulatory element for delta 12-prostaglandin J2-induced expression of the rat heme oxygenase gene. J. Biol. Chem. 270, 21779-21784 (1995).
73. Hassan, I.R., and Gronert, K. 15-Lipoxygenase and docosahexaenoic acid derived lipid mediators ameliorate inflammation and augment heme oxygenase-1 expression in acute renal failure. Prostaglandins Other Lipid Mediat. 79, 158-158 (2006).
74. Duffield, J.S., Hong, S., Vaidya, V.S., Lu, Y., Fredman, G., Serhan, C.N., and Bonventre, J.V. Resolvin D series and protectin D1 mitigate acute kidney injury. J. Immunol. 177, 5902-5911 (2006).